THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 114 filers reported holding THERAPEUTICSMD INC in Q3 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,087,000 | +783.7% | 2,860,361 | +727.3% | 0.00% | – |
Q4 2021 | $123,000 | -66.4% | 345,743 | -30.0% | 0.00% | – |
Q3 2021 | $366,000 | +9.6% | 493,845 | +75.8% | 0.00% | – |
Q2 2021 | $334,000 | -86.6% | 280,954 | -84.9% | 0.00% | -100.0% |
Q1 2021 | $2,490,000 | +78.8% | 1,858,255 | +61.5% | 0.00% | – |
Q4 2020 | $1,393,000 | -57.9% | 1,150,805 | -45.0% | 0.00% | -100.0% |
Q3 2020 | $3,305,000 | +446.3% | 2,091,760 | +332.1% | 0.00% | – |
Q2 2020 | $605,000 | +19.8% | 484,116 | +1.6% | 0.00% | – |
Q1 2020 | $505,000 | -77.9% | 476,358 | -49.6% | 0.00% | -100.0% |
Q4 2019 | $2,288,000 | +92.9% | 945,705 | +189.6% | 0.00% | – |
Q3 2019 | $1,186,000 | -6.5% | 326,587 | -33.1% | 0.00% | – |
Q2 2019 | $1,268,000 | -63.0% | 487,882 | -30.7% | 0.00% | -100.0% |
Q1 2019 | $3,431,000 | +81.0% | 704,516 | +41.6% | 0.00% | 0.0% |
Q4 2018 | $1,896,000 | -73.8% | 497,609 | -54.9% | 0.00% | -50.0% |
Q3 2018 | $7,231,000 | +31.4% | 1,102,242 | +25.0% | 0.00% | +100.0% |
Q2 2018 | $5,504,000 | +138.3% | 882,095 | +86.0% | 0.00% | 0.0% |
Q1 2018 | $2,310,000 | -16.4% | 474,208 | +3.6% | 0.00% | 0.0% |
Q4 2017 | $2,764,000 | +23.3% | 457,582 | +8.0% | 0.00% | 0.0% |
Q3 2017 | $2,241,000 | +5.0% | 423,719 | +4.6% | 0.00% | – |
Q2 2017 | $2,134,000 | -23.0% | 404,901 | +5.1% | 0.00% | -100.0% |
Q1 2017 | $2,772,000 | +100.0% | 385,102 | +60.4% | 0.00% | – |
Q4 2016 | $1,386,000 | +42.4% | 240,163 | +68.1% | 0.00% | – |
Q3 2016 | $973,000 | -29.9% | 142,863 | -12.6% | 0.00% | – |
Q2 2016 | $1,389,000 | +8.7% | 163,371 | -18.2% | 0.00% | – |
Q1 2016 | $1,278,000 | -83.5% | 199,708 | -73.3% | 0.00% | -100.0% |
Q4 2015 | $7,764,000 | -15.7% | 748,725 | -52.4% | 0.00% | -25.0% |
Q3 2015 | $9,213,000 | +923.7% | 1,572,046 | +1272.6% | 0.00% | – |
Q2 2015 | $900,000 | -15.9% | 114,534 | -35.3% | 0.00% | – |
Q1 2015 | $1,070,000 | +540.7% | 176,904 | +371.3% | 0.00% | – |
Q4 2014 | $167,000 | -91.7% | 37,533 | -91.3% | 0.00% | -100.0% |
Q3 2014 | $2,010,000 | +1972.2% | 433,224 | +1869.6% | 0.00% | – |
Q2 2014 | $97,000 | -93.3% | 21,996 | -90.4% | 0.00% | – |
Q1 2014 | $1,447,000 | +28.1% | 229,314 | +5.7% | 0.00% | – |
Q4 2013 | $1,130,000 | +448.5% | 216,884 | +208.7% | 0.00% | – |
Q3 2013 | $206,000 | -64.5% | 70,250 | -63.3% | 0.00% | – |
Q2 2013 | $580,000 | – | 191,381 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |